XyloCor Therapeutics, a forward-thinking company in the biotechnology sector, is at the forefront of developing a promising new approach: a gene therapy candidate named XC001 (encoberminogene rezmadenovec)

Mental health is a crucial part of our overall well-being, yet for many people, especially those in underserved communities, getting the right mental health care can be incredibly difficult. They might face numerous obstacles, like a lack of local specialists, high costs, or the stigma often associated with seeking mental health support.

Depression is a widespread and debilitating condition, affecting millions globally. While various treatments exist, a significant portion of patients, often referred to as those with "treatment-resistant depression," find little to no relief from conventional therapies.